Dixon III Ken MD - 30501 Gainesville, GA

Business Name: Dixon III Ken MD
Categorized In: Doctors
Address: 690 Medical Park Lane, Gainesville, GA 30501
Phone Number: (770) 531-0093
Contact Person: Ken Dixon III
Website Address: livercancertreatment.org
NAICS Code: 6211110
SIC Code: 8011
Business Type: B2C (Business to Consumer)
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $500.000 to $999.999
Share This Business:
Similar Businesses: Aggarwall Deepak MD - Gainesville, GA 30501
Saleem Sohail MD - Gainesville, GA 30501
Sumner Sean M MD - Gainesville, GA 30501
Pierce Bradley H MD - Gainesville, GA 30501
Villaneuva Roberto M MD - Gainesville, GA 30501
Cook Meghan B MD - Gainesville, GA 30501
Gentin Miriam P MD - Gainesville, GA 30501
Terry Jeffrey C MD - Gainesville, GA 30501
Lovell Tracy L MD - Gainesville, GA 30501
Kowalske Brenda J MD - Gainesville, GA 30501
Goeckeritz Bruce E MD - Gainesville, GA 30501
Head Wesley D MD - Gainesville, GA 30501
Hulsey Kelly J MD - Gainesville, GA 30501
Surles Brenda B MD - Gainesville, GA 30501
Kid's Health At Sherwood Park - Gainesville, GA 30501
Crudgington Rachel A MD - Gainesville, GA 30501
Winston Alan D MD - Gainesville, GA 30501
Bedingfield Jr William N MD - Gainesville, GA 30501
Mullis Daniel A MD - Gainesville, GA 30501
Sheikh Mujtaba S MD - Gainesville, GA 30501

Dixon III Ken MD provides professional Doctors from its single location at the coordinates 34.32091,-83.79942.

The company offers B2C variables under the SIC code 8011 and NAICS code 6211110, while making an annual revenue of $500.000 to $999.999 and hiring a total of 1 to 4 employees.

Founded in 0, the company can now be visited at 690 Medical Park Lane, Gainesville, Georgia 30501 or contacted through representative Ken Dixon III at (770) 531-0093.

For frequently asked questions and further inquiries about professional Doctors, get to know more about Dixon III Ken MD through its company website at livercancertreatment.org. Engage with this business on its social media platforms through on Twitter and on Facebook.